SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-24-088100
Filing Date
2024-08-12
Accepted
2024-08-12 08:27:51
Documents
3
Group Members
EMERGING TECHNOLOGY PARTNERS, LLCETP BIOHEALTH III FUND, L.P.ETP GLOBAL FUND L.P.HE FAMILY GRATHUIYING MEMORIAL FOUNDATION

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2421415d1_sc13da.htm SC 13D/A 242362
2 EXHIBIT 99.1 tm2421415d1_ex99-1.htm EX-99.1 10878
3 EXHIBIT 99.2 tm2421415d1_ex99-2.htm EX-99.2 141432
  Complete submission text file 0001104659-24-088100.txt   396453
Mailing Address ENTREMED, INC. 9640 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address
He Wei-Wu (Filed by) CIK: 0001542073 (see all company filings)

Type: SC 13D/A

Mailing Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025
Business Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025 86 10 6561 8789
CASI Pharmaceuticals, Inc. (Subject) CIK: 0001962738 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-94039 | Film No.: 241194969
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)